Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
IGM Biosciences, Inc.
IGM Biosciences, Inc.
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
NYU Langone Health